BioAtla, Inc. (BCAB) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$59.30M | +19.8% |
| 2024 | -$73.94M | +43.0% |
| 2023 | -$129.69M | -19.9% |
| 2022 | -$108.14M | -12.1% |
| 2021 | -$96.44M | -220.4% |
| 2020 | -$30.10M | -6.5% |
| 2019 | -$28.27M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$59.30M | +19.8% |
| 2024 | -$73.94M | +43.0% |
| 2023 | -$129.69M | -19.9% |
| 2022 | -$108.14M | -12.1% |
| 2021 | -$96.44M | -220.4% |
| 2020 | -$30.10M | -6.5% |
| 2019 | -$28.27M | — |